Cite
HARVARD Citation
Coupe, N. et al. (n.d.). PACMEL: A phase 1 dose escalation trial of trametinib (GSK1120212) in combination with paclitaxel. European journal of cancer. 51 (3), pp. 359-366. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Coupe, N. et al. (n.d.). PACMEL: A phase 1 dose escalation trial of trametinib (GSK1120212) in combination with paclitaxel. European journal of cancer. 51 (3), pp. 359-366. [Online].